Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to... see more

OTCPK:MEDVF - Post Discussion

Medivolve Inc > 🔥🔥🔥WHY $QSC🔥🔥🔥
View:
Post by Northernvince on Aug 01, 2020 10:33pm

🔥🔥🔥WHY $QSC🔥🔥🔥

REFRESH $QSC -One of the 12 lateral flow test kit(10-15 min result covid 19) that have received the Emergency Use Autorisation by the FDA... -Best antibody test on the market coz of their technologie: coloidal gold (GOLD NANOPARTICULE in fluid)...yes gold nonaparticule!!! -Ceo director have many years of experience and connexions with biotech and big pharma... - they already submited application for point of care (poc) (waiting for approval) wich will allow them to partner with "cvs" and other major drug store as well... -partnership in place with professional sport teams... -clinical study : 2430 clinical patients tested - sensitivity: 100% specitivity: 98.8% -expected sale: 4 millions test by months 25$US/test... -North america exclusivity and solid print in south america... - Low MC (19 millions$) -Low float stock (90 millions shares) - still under the radar -Last webinar: https://questcapinc.com/questcap-corporate-update-investor-webinar-june-2020/ Worth a full watch but you can go straight to 40 min... -Last NR: https://ceo.ca/@nasdaq/questcap-secures-exclusive-sales-rights-for-emergency -Ceo director background: https://questcapinc.com/qc_team/doug-sommerville/ Connect the dots... GLTA !!!
Comment by Frediboy on Aug 01, 2020 11:07pm
That's right NorthernVince. Lots of value here. This puppy will be flying off the shelf. This market is huge all governments worlwide spending big money. Worst is yet to come in the fall Shout out to Sarb99 excellent post !!! GLTA
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities